1. Perjeta story doesn't tell it all
    John Baumann John Baumann United States says:
    July 12, 2012 at 6:53 AM

    It's wonderful that a new breast cancer drug is available. BUT ONLY AVAILABLE TO WOMEN WITH AN EARLY RECURRENCE. The FDA and the makers of Perjeta have not approved the drug for late stage metastatic breast cancer. WHY? Who knows. When breast cancer patients have gone through all of the available chemo drugs, and they know that Perjeta, is out there, it should be made available IMMEDIATELY.

    Or, maybe we should just give up hope. Why should my wife be denied a drug that might save her life?

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback